Zacks Research Has Bearish Forecast for Clorox Q1 Earnings

The Clorox Company (NYSE:CLXFree Report) – Equities research analysts at Zacks Research dropped their Q1 2027 earnings estimates for Clorox in a report issued on Tuesday, February 17th. Zacks Research analyst Team now anticipates that the company will post earnings of $1.31 per share for the quarter, down from their previous estimate of $1.32. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share. Zacks Research also issued estimates for Clorox’s Q4 2027 earnings at $2.30 EPS, Q1 2028 earnings at $1.37 EPS and FY2028 earnings at $7.23 EPS.

Several other research firms also recently commented on CLX. UBS Group boosted their price objective on Clorox from $115.00 to $121.00 and gave the company a “neutral” rating in a report on Wednesday, February 4th. Morgan Stanley boosted their price target on shares of Clorox from $125.00 to $136.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. The Goldman Sachs Group lowered their price objective on shares of Clorox from $110.00 to $94.00 and set a “sell” rating on the stock in a report on Wednesday, January 7th. Wall Street Zen raised shares of Clorox from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $114.00 to $117.00 and gave the company a “neutral” rating in a report on Wednesday, February 4th. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Reduce” and a consensus target price of $118.73.

Check Out Our Latest Stock Analysis on Clorox

Clorox Stock Down 0.9%

Shares of NYSE:CLX opened at $122.04 on Friday. The business’s 50 day simple moving average is $109.36 and its two-hundred day simple moving average is $113.68. The firm has a market cap of $14.76 billion, a P/E ratio of 19.94, a PEG ratio of 0.61 and a beta of 0.59. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.48 and a current ratio of 0.74. Clorox has a 52-week low of $96.66 and a 52-week high of $159.04.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The company had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the company earned $1.55 EPS. Clorox’s revenue for the quarter was down .8% compared to the same quarter last year.

Institutional Trading of Clorox

Institutional investors and hedge funds have recently made changes to their positions in the company. Haverford Trust Co boosted its holdings in Clorox by 2.8% during the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock worth $310,000 after purchasing an additional 84 shares during the last quarter. Savvy Advisors Inc. boosted its stake in shares of Clorox by 1.4% in the 2nd quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock worth $768,000 after buying an additional 91 shares during the last quarter. Canandaigua National Bank & Trust Co. boosted its stake in shares of Clorox by 0.8% in the 3rd quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock worth $1,380,000 after buying an additional 94 shares during the last quarter. State of Michigan Retirement System grew its holdings in shares of Clorox by 0.3% in the second quarter. State of Michigan Retirement System now owns 33,551 shares of the company’s stock valued at $4,028,000 after acquiring an additional 100 shares in the last quarter. Finally, Field & Main Bank increased its position in shares of Clorox by 3.3% during the fourth quarter. Field & Main Bank now owns 3,100 shares of the company’s stock valued at $313,000 after acquiring an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Trending Headlines about Clorox

Here are the key news stories impacting Clorox this week:

  • Positive Sentiment: Clorox published a new consumer study, “Home Care Redefined,” positioning its portfolio around wellness, convenience and younger consumer priorities — a marketing/innovation push that could support category relevance and pricing power over time. Home Care Redefined
  • Neutral Sentiment: Management presented at the Consumer Analyst Group of New York (CAGNY). The slides and prepared remarks provide updated strategic detail for investors (product/portfolio priorities, consumer insights and growth levers). These disclosures are informational and help frame execution risk, but are not a direct catalyst for near‑term earnings revisions. CAGNY Slides CAGNY Transcript
  • Negative Sentiment: Zacks Research trimmed multiple near‑term EPS forecasts (several quarters and FY2027 were reduced modestly), and kept a “Hold” stance — a direct negative to sentiment because lower analyst estimates can pressure the stock and reduce upside expectations. (Multiple estimate revisions issued Feb. 17.)
  • Negative Sentiment: Wells Fargo moved to a Hold on CLX, reinforcing a cautious view from major street analysts that likely contributed to selling pressure. Wells Fargo Hold

About Clorox

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Articles

Earnings History and Estimates for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.